IMPORTANCE OF CLASSIFYING INITIAL CO-MORBIDITY IN EVALUATING OUTCOME OF DIABETES-MELLITUS

被引：506

作者：

KAPLAN, MH

FEINSTEIN, AR

机构：

[1] YALE UNIV, SCH MED, NEW HAVEN, CT 06520 USA

[2] VET ADM HOSP, EASTERN COOPERAT STUDIES CTR, WEST HAVEN, CT USA

[3] YALE UNIV, HLTH SERV, NEW HAVEN, CT USA

来源：

JOURNAL OF CHRONIC DISEASES | 1974年 / 27卷 / 7-8期

关键词：

D O I：

10.1016/0021-9681(74)90017-4

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：387 / 404

页数：18

共 14 条

[1] BERKSON J, 1950, P STAFF M MAYO CLIN, V25, P270
[2] UNIVERSITY GROUP DIABETES PROGRAM - FURTHER STATISTICAL ANALYSIS OF MORTALITY FINDINGS
CORNFEIL.J
[J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1971, 217 (12) : 1676 - +
[3] CUTLER SJ, 1958, J CHRON DIS, V8, P699
[4] Feinstein A. R, 1967, CLIN JUDGMENT
[5] EPIDEMIOLOGY OF CANCER THERAPY .2. CLINICAL COURSE - DATA DECISIONS AND TEMPORAL DEMARCATIONS
FEINSTEIN, AR
PRITCHETT, JA
SCHIMPFF, CR
[J]. ARCHIVES OF INTERNAL MEDICINE, 1969, 123 (03) : 323 - +
[6] CLINICAL EPIDEMIOLOGY .3. CLINICAL DESIGN OF STATISTICS IN THERAPY
FEINSTEIN, AR
[J]. ANNALS OF INTERNAL MEDICINE, 1968, 69 (06) : 1287 - +
[7] FEINSTEIN AR, 1971, CLIN PHARMACOL THER, V12, P134
[8] PRE-THERAPEUTIC CLASSIFICATION OF CO-MORBIDITY IN CHRONIC DISEASE
FEINSTEIN, AR
[J]. JOURNAL OF CHRONIC DISEASES, 1970, 23 (07): : 455 - +
[9] FEINSTEIN AR, 1972, CLIN PHARMACOL THER, V13, P755
[10] FEINSTEIN AR, 1971, CLIN PHARMACOL THER, V12, P864